Physician

Abraham Kalikstein, M.D.

According to 2025 Medicare claims, Abraham Kalikstein, M.D. (NPI: 1245617927) practices neurology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Queens, NY. This provider's primary affiliated billing organization is NEW YORK NEUROLOGIC ASSOCIATES, LLP (NPI: 1083687198; TIN: 26-3355624) and primary practice location at 11042-1214.

Kalikstein's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 588 traditional Medicare patients, billed 3,693 HCPCS/CPT codes, and received $237,272 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,255 prescription claims across 284 beneficiaries totaling $1,310,710 in drug costs, led by Gammaplex (Immun Glob G(Igg)/Gly/Iga 0-50). Open Payments data shows 272 records totaling $4,094. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $19,770 to $1,310,710. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$119K$237K2021 Medicare payment: $143,383 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $193,745 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $235,510 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $237,272 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20213691,595$143,383
20224352,685$193,745
20234443,289$235,510
20245883,693$237,272

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$655K$1.3M2016 Drug cost: $19,770 (USD; Tot_Drug_Cst)2017 Drug cost: $12,587 (USD; Tot_Drug_Cst)2018 Drug cost: $20,059 (USD; Tot_Drug_Cst)2019 Drug cost: $7,763 (USD; Tot_Drug_Cst)2020 Drug cost: $2,327 (USD; Tot_Drug_Cst)2021 Drug cost: $58,400 (USD; Tot_Drug_Cst)2022 Drug cost: $500,480 (USD; Tot_Drug_Cst)2023 Drug cost: $816,707 (USD; Tot_Drug_Cst)2024 Drug cost: $1,310,710 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20161246$19,770
201740120$12,587
201839143$20,059
20191987$7,763
20202961$2,327
2021102240$58,400
2022118415$500,480
20232251,027$816,707
20242841,255$1,310,710

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes177185$147
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more114114$140
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more167240$78
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes149275$68
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's124169$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
GammaplexImmun Glob G(Igg)/Gly/Iga 0-5014368$239,276
GammakedImmune Globul G/Gly/Iga Avg 4621588$178,002
Gamunex-CImmune Globul G/Gly/Iga Avg 4616420$134,213
IngrezzaValbenazine Tosylate13390$107,289
Nurtec OdtRimegepant Sulfate15450$28,384

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.272$4,094ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abraham Kalikstein, M.D.?

Tedicare shows public-source Medicare data for Abraham Kalikstein, M.D. (NPI 1245617927), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abraham Kalikstein, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abraham Kalikstein, M.D.?

Abraham Kalikstein, M.D. is linked to NEW YORK NEUROLOGIC ASSOCIATES, LLP (billing NPI 1083687198) in the available physician profile data.

Does Abraham Kalikstein, M.D. have Open Payments data?

Abraham Kalikstein, M.D. has 272 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.